(Q81305181)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17873917%20AND%20SRC:MED&resulttype=core&format=json

7 January 2020

title

Effect of prior rituximab on high-dose therapy and autologous stem cell transplantation in follicular lymphoma (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17873917%20AND%20SRC:MED&resulttype=core&format=json

stem cell transplantation

7 January 2020

main subject

1 reference

1 reference

1 reference

Kang TY

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17873917%20AND%20SRC:MED&resulttype=core&format=json

7 January 2020

Rybicki LA

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17873917%20AND%20SRC:MED&resulttype=core&format=json

7 January 2020

Bolwell BJ

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17873917%20AND%20SRC:MED&resulttype=core&format=json

7 January 2020

Thakkar SG

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17873917%20AND%20SRC:MED&resulttype=core&format=json

7 January 2020

Brown S

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17873917%20AND%20SRC:MED&resulttype=core&format=json

7 January 2020

Dean R

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17873917%20AND%20SRC:MED&resulttype=core&format=json

7 January 2020

Sekeres MA

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17873917%20AND%20SRC:MED&resulttype=core&format=json

7 January 2020

Advani A

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17873917%20AND%20SRC:MED&resulttype=core&format=json

7 January 2020

Sobecks R

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17873917%20AND%20SRC:MED&resulttype=core&format=json

7 January 2020

Kalaycio M

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17873917%20AND%20SRC:MED&resulttype=core&format=json

7 January 2020

Pohlman B

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17873917%20AND%20SRC:MED&resulttype=core&format=json

7 January 2020

Sweetenham JW

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17873917%20AND%20SRC:MED&resulttype=core&format=json

7 January 2020

publication date

17 September 2007

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17873917%20AND%20SRC:MED&resulttype=core&format=json

Bone Marrow Transplantation

7 January 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17873917%20AND%20SRC:MED&resulttype=core&format=json

7 January 2020

volume

40

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17873917%20AND%20SRC:MED&resulttype=core&format=json

7 January 2020

issue

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17873917%20AND%20SRC:MED&resulttype=core&format=json

7 January 2020

page(s)

973-978

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17873917%20AND%20SRC:MED&resulttype=core&format=json

Rituximab chimeric anti-CD20 monoclonal antibody therapy for relapsed indolent lymphoma: half of patients respond to a four-dose treatment program.

7 January 2020

cites work

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705849

7 January 2021

IDEC-C2B8 (Rituximab) anti-CD20 antibody treatment in relapsed advanced-stage follicular lymphomas: results of a phase-II study of the German Low-Grade Lymphoma Study Group

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705849

7 January 2021

CVP chemotherapy plus rituximab compared with CVP as first-line treatment for advanced follicular lymphoma

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705849

7 January 2021

Frontline therapy with rituximab added to the combination of cyclophosphamide, doxorubicin, vincristine, and prednisone (CHOP) significantly improves the outcome for patients with advanced-stage follicular lymphoma compared with therapy with CHOP al

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705849

7 January 2021

High-dose therapy improves progression-free survival and survival in relapsed follicular non-Hodgkin's lymphoma: results from the randomized European CUP trial

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705849

7 January 2021

The central role of the propensity score in observational studies for causal effects

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705849

7 January 2021

Comparison in low-tumor-burden follicular lymphomas between an initial no-treatment policy, prednimustine, or interferon alfa: a randomized study from the Groupe d'Etude des Lymphomes Folliculaires. Groupe d'Etude des Lymphomes de l'Adulte

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705849

7 January 2021

Long-term effect of a watch and wait policy versus immediate systemic treatment for asymptomatic advanced-stage non-Hodgkin lymphoma: a randomised controlled trial

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705849

7 January 2021

Patterns of survival in patients with recurrent follicular lymphoma: a 20-year study from a single center

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705849

7 January 2021

High-dose therapy with autologous bone marrow support as consolidation of remission in follicular lymphoma: long-term clinical and molecular follow-up

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705849

7 January 2021

Long-Term Follow-Up of Indolent Lymphoma Patients Treated With High-Dose Sequential Chemotherapy and Autografting: Evidence That Durable Molecular and Clinical Remission Frequently Can Be Attained Only in Follicular Subtypes

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705849

7 January 2021